Tumor and serum tamoxifen concentrations in the athymic nude mouse

Michael W. DeGregorio, Ester Coronado, C. Kent Osborne

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The athymic nude mouse has been used as an in vivo model for pharmacologic studies of the antiestrogen, tamoxifen. Serum and tumor tamoxifen and metabolite concentrations were examined during and after 100 and 1000 μg/day doses injected s.c. Tamoxifen and tamoxifen metabolites were quantitated by high-performance liquid chromatography. Tamoxifen was detected in tumors after a dose of 100 μg/day, although serum concentrations were not detected. At a dose of 1000 μg/day, tumor tamoxifen and its active metabolites were detected in high concentrations ranging up to >6 mmol/g tissue. Serum tamoxifen metabolites were not detected at either dose. In summary, high doses of tamoxifen were required in the nude mouse to obtain clinically relevant serum concentrations, and significant tumor levels were achieved at doses that resulted in undetectable serum levels. The relationship between serum tamoxifen concentrations, tumor tamoxifen levels, and the biologic activity of the drug requires further study.

Original languageEnglish (US)
Pages (from-to)68-70
Number of pages3
JournalCancer Chemotherapy and Pharmacology
Volume23
Issue number2
DOIs
StatePublished - Feb 1989
Externally publishedYes

Fingerprint

Tamoxifen
Nude Mice
Tumors
Serum
Neoplasms
Metabolites
Estrogen Receptor Modulators
High performance liquid chromatography
High Pressure Liquid Chromatography
Tissue

ASJC Scopus subject areas

  • Pharmacology
  • Oncology
  • Cancer Research

Cite this

Tumor and serum tamoxifen concentrations in the athymic nude mouse. / DeGregorio, Michael W.; Coronado, Ester; Kent Osborne, C.

In: Cancer Chemotherapy and Pharmacology, Vol. 23, No. 2, 02.1989, p. 68-70.

Research output: Contribution to journalArticle

DeGregorio, Michael W. ; Coronado, Ester ; Kent Osborne, C. / Tumor and serum tamoxifen concentrations in the athymic nude mouse. In: Cancer Chemotherapy and Pharmacology. 1989 ; Vol. 23, No. 2. pp. 68-70.
@article{c792553b3bb44d8db284a9f9ecbc9956,
title = "Tumor and serum tamoxifen concentrations in the athymic nude mouse",
abstract = "The athymic nude mouse has been used as an in vivo model for pharmacologic studies of the antiestrogen, tamoxifen. Serum and tumor tamoxifen and metabolite concentrations were examined during and after 100 and 1000 μg/day doses injected s.c. Tamoxifen and tamoxifen metabolites were quantitated by high-performance liquid chromatography. Tamoxifen was detected in tumors after a dose of 100 μg/day, although serum concentrations were not detected. At a dose of 1000 μg/day, tumor tamoxifen and its active metabolites were detected in high concentrations ranging up to >6 mmol/g tissue. Serum tamoxifen metabolites were not detected at either dose. In summary, high doses of tamoxifen were required in the nude mouse to obtain clinically relevant serum concentrations, and significant tumor levels were achieved at doses that resulted in undetectable serum levels. The relationship between serum tamoxifen concentrations, tumor tamoxifen levels, and the biologic activity of the drug requires further study.",
author = "DeGregorio, {Michael W.} and Ester Coronado and {Kent Osborne}, C.",
year = "1989",
month = "2",
doi = "10.1007/BF00273519",
language = "English (US)",
volume = "23",
pages = "68--70",
journal = "Cancer Chemotherapy and Pharmacology",
issn = "0344-5704",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Tumor and serum tamoxifen concentrations in the athymic nude mouse

AU - DeGregorio, Michael W.

AU - Coronado, Ester

AU - Kent Osborne, C.

PY - 1989/2

Y1 - 1989/2

N2 - The athymic nude mouse has been used as an in vivo model for pharmacologic studies of the antiestrogen, tamoxifen. Serum and tumor tamoxifen and metabolite concentrations were examined during and after 100 and 1000 μg/day doses injected s.c. Tamoxifen and tamoxifen metabolites were quantitated by high-performance liquid chromatography. Tamoxifen was detected in tumors after a dose of 100 μg/day, although serum concentrations were not detected. At a dose of 1000 μg/day, tumor tamoxifen and its active metabolites were detected in high concentrations ranging up to >6 mmol/g tissue. Serum tamoxifen metabolites were not detected at either dose. In summary, high doses of tamoxifen were required in the nude mouse to obtain clinically relevant serum concentrations, and significant tumor levels were achieved at doses that resulted in undetectable serum levels. The relationship between serum tamoxifen concentrations, tumor tamoxifen levels, and the biologic activity of the drug requires further study.

AB - The athymic nude mouse has been used as an in vivo model for pharmacologic studies of the antiestrogen, tamoxifen. Serum and tumor tamoxifen and metabolite concentrations were examined during and after 100 and 1000 μg/day doses injected s.c. Tamoxifen and tamoxifen metabolites were quantitated by high-performance liquid chromatography. Tamoxifen was detected in tumors after a dose of 100 μg/day, although serum concentrations were not detected. At a dose of 1000 μg/day, tumor tamoxifen and its active metabolites were detected in high concentrations ranging up to >6 mmol/g tissue. Serum tamoxifen metabolites were not detected at either dose. In summary, high doses of tamoxifen were required in the nude mouse to obtain clinically relevant serum concentrations, and significant tumor levels were achieved at doses that resulted in undetectable serum levels. The relationship between serum tamoxifen concentrations, tumor tamoxifen levels, and the biologic activity of the drug requires further study.

UR - http://www.scopus.com/inward/record.url?scp=0024210066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024210066&partnerID=8YFLogxK

U2 - 10.1007/BF00273519

DO - 10.1007/BF00273519

M3 - Article

C2 - 2910513

AN - SCOPUS:0024210066

VL - 23

SP - 68

EP - 70

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

SN - 0344-5704

IS - 2

ER -